A Study to Determine How Tebapivat is Absorbed, Broken Down, and Removed From the Body and the Extent to Which Tebapivat is Made Available in the Body in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

February 21, 2025

Study Completion Date

February 21, 2025

Conditions

Healthy Participants

Interventions

DRUG

[14C]-tebapivat

Oral Capsule

DRUG

[13C2,15N3]-tebapivat

Intravenous Solution

Trial Locations (1)

Taha El-Shahat, Madison